Search

everythinglearnresearchcommunity

for

Search:↓

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Monoclonal antibodies are often linked to alopecia areata cases.

ADM scaffolds help skin heal by promoting a healing-type immune response.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

The ammonia-free hair dye is safe and improves hair shine, color, moisture, porosity, and combability.

A new microneedle patch effectively and safely treats alopecia areata.

A certain gene variation can affect protein production and is linked to male pattern baldness.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Arg1+ macrophages may play a role in causing alopecia areata.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

IMA and IMA/albumin levels don't predict alopecia areata severity.

AMPD is a better and less damaging alternative to ammonium hydroxide for hair bleaching.

Ischemia-modified albumin can help diagnose ischemic conditions early, but better detection methods are needed.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

DALL-E 2 can create realistic hair images but struggles with specific hair disorders.

The new model improves Alopecia Areata classification accuracy to 93.1%.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Generative AI tools can accurately score alopecia areata, reducing subjectivity in evaluations.

The new AI system accurately diagnoses hair disorders and offers personalized treatment recommendations.

Apremilast may help treat hair loss in alopecia areata.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.